Retinal Degeneration
Showing 26 - 50 of 3,948
Retinal Care Data Repository
Not yet recruiting
- Diabetic Retinopathy
- Age Related Macular Degeneration
- Observation
- (no location specified)
Oct 24, 2022
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Shanghai (BD311)
Recruiting
- Neovascular Age-related Macular Degeneration
- +2 more
- BD311
-
Shanghai, Shanghai, ChinaEye & ENT Hospital of Fudan University
Aug 22, 2022
Neovascular Age-related Macular Degeneration Trial in Phoenix (CLS-AX, Aflibercept)
Recruiting
- Neovascular Age-related Macular Degeneration
-
Phoenix, ArizonaRetinal Research Institute, LLC
Jun 4, 2023
Retinitis Pigmentosa, Retinitis, Retinal Diseases Trial in Puerto Rico, United States (Gene Therapy Product-vMCO-010, Sham
Active, not recruiting
- Retinitis Pigmentosa
- +6 more
- Gene Therapy Product-vMCO-010
- Sham Injection
-
Beverly Hills, California
- +6 more
Jul 13, 2022
Rate of Progression in USH2A-related Retinal Degeneration
Active, not recruiting
- Usher Syndrome, Type 2A
- Retinitis Pigmentosa 39
-
San Francisco, California
- +15 more
Mar 8, 2022
Diagnostic Possibilities in Ophthalmological Diseases Using
Recruiting
- Retinal Disease
- +2 more
- SS-OCT system Plex Elite 9000
-
Linz, Oberösterreich, AustriaDepartment for Ophthalmology and Optometry, Kepler University Ho
Oct 3, 2023
Glaucoma Eye, Macular Degeneration, Macula Abnormality Trial in Helsingborg (Hyperspectral retinal image, Mydriacyl Ophthalmic
Enrolling by invitation
- Glaucoma Eye
- +3 more
- Hyperspectral retinal image
- Mydriacyl Ophthalmic Product
-
Helsingborg, Skåne Län, SwedenSundets Ögonläkare
Oct 20, 2022
Functional Optical Coherence Tomography for Ocular Imaging
Completed
- Glaucoma
- +4 more
- Optical Coherence Tomography
-
Irvine, CaliforniaBeckman Laser Institute, University of California,Irvine
Oct 19, 2022
Cone-Rod Degeneration, Rod-Cone Degeneration Trial in Bethesda, Sydney (VR Motility Tool)
Recruiting
- Cone-Rod Degeneration
- Rod-Cone Degeneration
- VR Motility Tool
-
Bethesda, Maryland
- +1 more
Feb 2, 2023
Neovascular Age-related Macular Degeneration, Retinal Disease, Retinal Degeneration Trial in United States (GEM103, sham + SoC)
Completed
- Neovascular Age-related Macular Degeneration
- +3 more
- GEM103
- sham + SoC
-
Phoenix, Arizona
- +22 more
Mar 22, 2022
Age-related Macular Degeneration Trial in Israel, United States (OpRegen)
Completed
- Age-Related Macular Degeneration
- OpRegen
- (no location specified)
Nov 1, 2022
Inherited Retinal Dystrophies Using Whole Genome Sequencing and
Recruiting
- Inherited Retinal Dystrophy
- +2 more
- whole genome sequencing
-
Rome, ItalyIstituto Superiore di Sanità-Dpt. Oncology and Molecular Medicin
Mar 30, 2023
Study of Retinal Dystrophies Associated With Rare
Active, not recruiting
- Inherited Retinal Degeneration
- Retinitis Pigmentosa
-
Phoenix, Arizona
- +23 more
Jan 24, 2023
Rate of Progression in EYS Related Retinal Degeneration
Active, not recruiting
- Retinitis Pigmentosa
- Eye Diseases
-
San Francisco, California
- +19 more
Feb 3, 2022
Retinal Disease, Retinal Degeneration, Retinal Dystrophies Trial in Oxford (Long-wavelength autofluorescence imaging)
Recruiting
- Retinal Disease
- +2 more
- Long-wavelength autofluorescence imaging
-
Oxford, United KingdomOxford Eye Hospital
Jul 20, 2021
Vitreoretinopathy, Coats' Disease, Exudative Retinopathy Trial in Durham (Dextenza 0.4Mg Ophthalmic Insert, Pred Forte)
Not yet recruiting
- Vitreoretinopathy
- +8 more
- Dextenza 0.4Mg Ophthalmic Insert
- Pred Forte
-
Durham, North CarolinaDuke Eye Center
Nov 10, 2022
Neovascular Age-related Macular Degeneration, Age-related Macular Degeneration, Diabetic Retinopathy Trial in Durham (AngioVue
Terminated
- Neovascular Age-related Macular Degeneration
- +4 more
- AngioVue SD-OCT
-
Durham, North CarolinaDuke Eye Center
Mar 29, 2022
Wet Macular Degeneration Trial in Prague (Aflibercept 40 MG/ML [Eylea], Brolucizumab-Dbll 120 MG/ML [Beovu], Ranibizumab 6 MG/ML
Withdrawn
- Wet Macular Degeneration
- Aflibercept 40 MG/ML [Eylea]
- +2 more
-
Prague, CzechiaDepartment of Ophthalmology, Faculty hospital Kralovske Vinohrad
Aug 7, 2022
Age-Related Maculopathy, Age-Related Maculopathies, Eye Diseases Trial in United States (RN6G, Placebo)
Completed
- Age-Related Maculopathy
- +4 more
- RN6G
- Placebo
-
Campbell, California
- +23 more
May 10, 2022
Macular Degeneration Trial in Beijing (Autologous iPSC-derived RPE)
Recruiting
- Macular Degeneration
- Autologous iPSC-derived RPE
-
Beijing, Beijing, ChinaBeijing Tongren Hospitol,Capital Medical University
Jun 30, 2022
Multimodal Imaging in Vitreo-retinal Surgery and Macular
Active, not recruiting
- Macular Holes
- +3 more
- Biometry
- +4 more
-
Rome, ItalyProf. Stanislao Rizzo
Feb 17, 2023
Age-Related Macular Degeneration Trial (Cultured retinal stem and progenitor cells, Standard treatment according to the clinical
Not yet recruiting
- Age-Related Macular Degeneration
- Cultured retinal stem and progenitor cells
- Standard treatment according to the clinical protocols
- (no location specified)
Dec 24, 2021
Healthy, Macular Edema, Macular Degeneration Trial in Helsinki (ERG electrode tests for fundus image-guided focal ERG, Fundus
Completed
- Healthy
- +2 more
- ERG electrode tests for fundus image-guided focal ERG
- Fundus image-guided focal ERG
-
Helsinki, Uusimaa, FinlandHelsinki University Hospital, Retinal Outpatient Clinic
Nov 7, 2022
Retinal Imaging in Patients With Inherited Retinal Degenerations
Recruiting
- Retinitis Pigmentosa
-
San Francisco, CaliforniaDepartment of Ophthalmology Retinal Degenerations Clinic, UCSF
Sep 23, 2021
Age Related Macular Degeneration Trial in Lyon (Blood samples)
Recruiting
- Age Related Macular Degeneration
- Blood samples
-
Lyon, FranceService d'ophtalmologie-HOSPICES CIVILS DE LYON - Hôpital de la
Jun 9, 2022